Delta Opioid Receptor Identified as Promising Therapeutic Target for Inflammatory Pain Relief

  Delta opioid receptors have a built-in mechanism for pain relief and can be precisely targeted with drug-delivering nanoparticles—making them a promising target for treating chronic inflammatory pain with fewer side effects, according to a new study from an international team of researchers. The study is published in Proceedings of the National Academy of Sciences. Full story.